Volume 87 Issue 7 | p. 34 | Concentrates
Issue Date: February 16, 2009

Senate Bill Targets Generic Drug Delays

Department: Government & Policy

Legislation introduced in the Senate would prohibit pharmaceutical companies with brand-name medicines from paying makers of generic drugs to delay introduction of the less expensive but equivalent products. “It’s time to stop these drug company pay-for-delay deals that only serve the profits of the companies involved and deny consumers access to affordable generic drugs,” says Sen. Herbert H. Kohl (D-Wis.), the bill’s chief sponsor. “With this legislation (S. 369), we . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society